Trend
DailyUptrend (confirmed)
4 hourBullish
1 hourAscending Triangle
15 minLeaning Bullish
5 minConsolidating
Daily trend turns down below $217.55
Key levels
Resistance$246.25
Resistance$238.46
Support$230.65
Support$222.96
Latest news & SEC filings
SEC FilingDanaher Corp filed an insider trading report (Form 4)
ProductCepheid's Xpert Respiratory Panel gets CE Marking under IVDR
ProductCepheid's Xpert Respiratory Panel Earns European Clearance
All DHR news →Danaher operates in the life sciences and diagnostics sectors, providing products and services used in research, clinical testing, and healthcare delivery. Its offerings include molecular diagnostics, laboratory instruments, and biotechnology tools sold to hospitals, laboratories, pharmaceutical companies, and research institutions. The company serves customers worldwide, with a substantial portion of sales outside the United States, including China.
Based on the company's 10-K filed Feb 24, 2026.
NYSE · Technology
SEPT Low Target
$195.00
SEPT Mid Target
$250.00
SEPT High Target
$270.00
Analyst Consensus
$250.00
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for DHR.
Start Free Trial →Valuation Verdict
FAIR
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$243.11
47
Moat Score
NARROW
5/9
Piotroski Score
N/A
Altman Z-Score
Insider Signal
SELLING
0 buys / 7 sells (90d)
Congress Signal
BUYING
11 buys / 9 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| McGrew Matthew | officer | Buy | 17,385 | $1.5M | Nov 9, 2026 |
| McGrew Matthew | officer | Sale | 17,385 | $4.1M | Nov 9, 2026 |
| Milosevich Gregory M | officer | Sale | 2,100 | $484K | Nov 9, 2026 |
| Bouda Christopher | officer | Buy | 4,345 | $307K | Oct 28, 2026 |
| Bouda Christopher | officer | Sale | 4,345 | $1.0M | Oct 28, 2026 |
| Bouda Christopher | officer | Buy | 3,253 | $230K | Oct 28, 2026 |
| Bouda Christopher | officer | Sale | 3,253 | $763K | Oct 28, 2026 |
| McGrew Matthew | officer | Sale | 14,151 | $3.3M | Oct 28, 2026 |
| McGrew Matthew | officer | Buy | 15,603 | $1.2M | Oct 28, 2026 |
| McGrew Matthew | officer | Sale | 15,603 | $3.7M | Oct 28, 2026 |
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
2.9%
3yr Revenue CAGR
-2.7%
EPS Growth YoY
-4.54%
FCF Growth YoY
-0.7%
Revenue Trend
ACCELERATING
SEPT Investing tracks real-time dark pool institutional trades for DHR, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 14:35:22 | $233.00 | 7,240 | $$1.7M | MIDPOINT |
| 14:35:02 | $233.91 | 67,467 | $$15.8M | SELL |
| 14:35:01 | $234.06 | 6,500 | $$1.5M | MIDPOINT |
| 14:34:38 | $234.44 | 2,247 | $$527K | BUY |
| 14:32:43 | $234.40 | 1,000 | $$234K | MIDPOINT |
5 dark pool trades shown · $$19.8M preview volume
Real-time institutional flow, block trades, and net positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for DANAHER CORP /DE/ (DHR) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →DANAHER CORP /DE/ (DHR) is at $232.73, down 1.10% (-$2.58) at the Nov 12, 2026 close.
Latest DHR news — Nov 10, 2026: Danaher Corp filed an insider trading report (Form 4) · Nov 10, 2026: Cepheid's Xpert Respiratory Panel gets CE Marking under IVDR
The average analyst price target for DHR is $250.00, ranging from $195 to $270, based on 16 analysts. Latest: Stifel maintains on Oct 22, 2026.
Analyst ratings for DHR: 0 Buy, 18 Hold, 0 Sell — consensus Hold.
DHR last reported on Oct 21, 2026: EPS $2.11 vs $1.92 expected — a beat of 9.9%.
DHR trades at a P/E of 38.4 vs a Technology average of 28.1.
Yes. DHR's dividend yield is 0.54%.
Support: $230.65, $222.96, $211.72. Resistance: $238.46, $246.25, $258.23.
Insider activity: SELLING, 0 buys and 7 sells in the last 90 days.
Nov 10, 2026: Danaher Corp filed an insider trading report (Form 4) · Nov 10, 2026: Cepheid's Xpert Respiratory Panel gets CE Marking under IVDR · Nov 10, 2026: Cepheid's Xpert Respiratory Panel Earns European Clearance